LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Back to the Future With Iconacy Orthopedics?
Large Joints and Extremities

Back to the Future With Iconacy Orthopedics?

October 5, 2012 1 min read Premium comments

Advertisement

Back to the Future With Iconacy Orthopedics?
Source: Courtesy of Iconacy Orthopedics, Inc.
Secondary

Is the space between the executive suite at these multi-billion, diversified orthopedic companies in Indiana, Tennessee or Michigan and the rank and file orthopedic surgeon now a chasm of Grand Canyon proportions?

The team at Iconacy Orthopedic Implants, LLC in Warsaw thinks so and have decided to do their level best to correct the problem.

Earlier last month, the young company announced that it had received its first FDA clearance to market a total hip replacement system under the trademark name I-Hip. The company defines the I-Hip system as consisting of “femoral stem and acetabular cup porous coated components intended for cement-less, press-fit fixation, patented highly cross-linked polyethylene liners, and Co-Cr alloy femoral heads.”

Products such as the I-Hip system align well with our overall strategy of providing clinically proven geometries of the highest quality while advancing technology, ” said Kevin Cox, VP of Sales and Marketing. “This system will allow us to deliver a best in class hip with advanced wear characteristics at an optimum value.

According to its press release, ICONACY was founded in 2009 “with a view focusing on the needs of patients, surgeons, and hospitals without the bureaucracy and costly infrastructure of a large organization.” The company plans to produce all of its products—hip, knee and shoulder replacements—in the United States.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy